Applied Therapeutics Stock Market Value
| APLT Stock | USD 0.10 0 3.00% |
| Symbol | Applied |
Is there potential for Biotechnology market expansion? Will Applied introduce new products? Factors like these will boost the valuation of Applied Therapeutics. If investors know Applied will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Applied Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.10) | Revenue Per Share | Quarterly Revenue Growth 7.197 | Return On Assets | Return On Equity |
The market value of Applied Therapeutics is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Applied Therapeutics' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Applied Therapeutics' market value can be influenced by many factors that don't directly affect Applied Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Applied Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Applied Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Applied Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Applied Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Applied Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Applied Therapeutics.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in Applied Therapeutics on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Applied Therapeutics or generate 0.0% return on investment in Applied Therapeutics over 90 days. Applied Therapeutics is related to or competes with GeoVax Labs, BioLineRx, Tharimmune, Ainos, and Lipocine. Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular... More
Applied Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Applied Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Applied Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.20) | |||
| Maximum Drawdown | 83.66 | |||
| Value At Risk | (15.73) | |||
| Potential Upside | 10.0 |
Applied Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Applied Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Applied Therapeutics' standard deviation. In reality, there are many statistical measures that can use Applied Therapeutics historical prices to predict the future Applied Therapeutics' volatility.| Risk Adjusted Performance | (0.15) | |||
| Jensen Alpha | (2.35) | |||
| Total Risk Alpha | (3.70) | |||
| Treynor Ratio | 2.92 |
Applied Therapeutics February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.15) | |||
| Market Risk Adjusted Performance | 2.93 | |||
| Mean Deviation | 7.02 | |||
| Coefficient Of Variation | (517.12) | |||
| Standard Deviation | 12.45 | |||
| Variance | 155.08 | |||
| Information Ratio | (0.20) | |||
| Jensen Alpha | (2.35) | |||
| Total Risk Alpha | (3.70) | |||
| Treynor Ratio | 2.92 | |||
| Maximum Drawdown | 83.66 | |||
| Value At Risk | (15.73) | |||
| Potential Upside | 10.0 | |||
| Skewness | (2.96) | |||
| Kurtosis | 15.01 |
Applied Therapeutics Backtested Returns
Applied Therapeutics secures Sharpe Ratio (or Efficiency) of -0.14, which signifies that the company had a -0.14 % return per unit of risk over the last 3 months. Applied Therapeutics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Applied Therapeutics' Standard Deviation of 12.45, mean deviation of 7.02, and Risk Adjusted Performance of (0.15) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.83, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Applied Therapeutics are expected to decrease at a much lower rate. During the bear market, Applied Therapeutics is likely to outperform the market. At this point, Applied Therapeutics has a negative expected return of -1.24%. Please make sure to confirm Applied Therapeutics' variance, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if Applied Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.30 |
Below average predictability
Applied Therapeutics has below average predictability. Overlapping area represents the amount of predictability between Applied Therapeutics time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Applied Therapeutics price movement. The serial correlation of 0.3 indicates that nearly 30.0% of current Applied Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.3 | |
| Spearman Rank Test | -0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Applied Stock Analysis
When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.